Post-approval studies (Phase 4)Study completedNCT03006419
What this trial is testing
Basiliximab vs Low-dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients
Who this might be right for
Kidney Transplant RejectionKidney Transplant; Complications
Coordinación de Investigación en Salud, Mexico 100